Live-seq brings longitudinal, non-destructive cell sequencing to every lab, revealing new insights into cellular behavior Zürich, Switzerland, and Vienna, Austria – Cytosurge AG, a leader in single-cell manipulation technologies, and Lexogen, a pioneer in RNA sequencing solutions, today announced that their integrated Live-seq workflow is now available to academic researchers and industry partners worldwide. This breakthrough enables labs […]
ANN ARBOR, MI — Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to expand access to Akadeum’s next-generation cell isolation technology for cell and gene therapy development. Under the agreement, Cayman will distribute Akadeum’s portfolio of buoyant […]
Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific instrumentation, has been awarded the Silver Medal by EcoVadis, a globally recognized provider of business sustainability ratings. Wetzlar, Germany – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific instrumentation, has been awarded the Silver Medal by EcoVadis, a globally […]
Mastermind® FLEX Data powers Compass Bioinformatics’s InheriNext® platform, bringing unparalleled genomic evidence to leading institutes across US, Japan, and beyond while advancing precision medicine globally Ann Arbor, MI, USA and Tokyo, Japan – Genomenon, a leading genomic intelligence company, today announced a strategic partnership with Compass Bioinformatics, integrating Genomenon’s Mastermind FLEX Data into Compass Bioinformatic’s innovative […]
LEIDEN, Netherlands — Ncardia, a leader in stem cell–based solutions for drug discovery and safety assessment, today announced the launch of Ncyte® NHP-C vCardiomyocytes, the first commercially available ventricular-like cardiomyocytes derived from induced pluripotent stem cells (iPSCs) of cynomolgus monkeys. New Ncyte® NHP-C vCardiomyocytes provide a scalable, ethical and translational tool for cross-species cardiac studies. The […]
Waddinxveen (NL) — INTEGRA Biosciences Group, a leading provider of laboratory tools for liquid handling and media preparation based in Switzerland, is buying shares in CleanNA, an established reagent manufacturer based in the Netherlands. This initial investment will cement a long-term strategic collaboration between the two companies, with a view to expanding CleanNA’s global reach and […]
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expression Portfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elements Sheffield, UK — SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, […]
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the TruSight™ Oncology (TSO) Comprehensive genomic profiling test. The continued expansion of tumor-agnostic CDx claims underscores Illumina’s commitment to advance access for […]
SALT LAKE CITY and BOSTON — Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad’s advanced laboratory capabilities in the […]
Introduction Monoclonal antibodies (mAbs) remain one of the most widely used therapeutic modalities across oncology, autoimmune diseases, and infectious diseases. In upstream development, accurate and timely measurement of mAb concentration is essential for clone selection, process optimisation, and early screening workflows. Conventional techniques such as enzyme-linked immunosorbent assays (ELISA) and conventional high-performance liquid chromatography (HPLC) […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
